Northern Trust’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-923,900
| Closed | -$17.4M | – | 4361 |
|
|
2019
Q3 | $17.4M | Buy |
923,900
+142,078
| +18% | +$2.68M | ﹤0.01% | 1781 |
|
|
2019
Q2 | $9.2M | Buy |
781,822
+31,794
| +4% | +$374K | ﹤0.01% | 2206 |
|
|
2019
Q1 | $10.2M | Buy |
750,028
+48,559
| +7% | +$663K | ﹤0.01% | 2126 |
|
|
2018
Q4 | $7.19M | Sell |
701,469
-8,973
| -1% | -$92K | ﹤0.01% | 2283 |
|
|
2018
Q3 | $11.8M | Buy |
710,442
+11,086
| +2% | +$185K | ﹤0.01% | 2164 |
|
|
2018
Q2 | $11.1M | Sell |
699,356
-5,493
| -0.8% | -$86.8K | ﹤0.01% | 2208 |
|
|
2018
Q1 | $8.95M | Buy |
704,849
+2,245
| +0.3% | +$28.5K | ﹤0.01% | 2239 |
|
|
2017
Q4 | $8.05M | Sell |
702,604
-26,923
| -4% | -$308K | ﹤0.01% | 2335 |
|
|
2017
Q3 | $8.94M | Buy |
729,527
+160,236
| +28% | +$1.96M | ﹤0.01% | 2274 |
|
|
2017
Q2 | $6.52M | Buy |
569,291
+11,544
| +2% | +$132K | ﹤0.01% | 2455 |
|
|
2017
Q1 | $11.6M | Buy |
557,747
+5,259
| +1% | +$109K | ﹤0.01% | 2019 |
|
|
2016
Q4 | $11.5M | Buy |
552,488
+3,331
| +0.6% | +$69.3K | ﹤0.01% | 2017 |
|
|
2016
Q3 | $18M | Sell |
549,157
-8,057
| -1% | -$264K | 0.01% | 1670 |
|
|
2016
Q2 | $13.9M | Buy |
557,214
+289,387
| +108% | +$7.23M | ﹤0.01% | 1794 |
|
|
2016
Q1 | $6.56M | Buy |
267,827
+4,870
| +2% | +$119K | ﹤0.01% | 2248 |
|
|
2015
Q4 | $8.69M | Buy |
262,957
+7,894
| +3% | +$261K | ﹤0.01% | 2108 |
|
|
2015
Q3 | $8.36M | Buy |
255,063
+126,248
| +98% | +$4.14M | ﹤0.01% | 2117 |
|
|
2015
Q2 | $6.82M | Buy |
128,815
+15,339
| +14% | +$813K | ﹤0.01% | 2314 |
|
|
2015
Q1 | $3.27M | Buy |
113,476
+29,591
| +35% | +$854K | ﹤0.01% | 2793 |
|
|
2014
Q4 | $2.44M | Sell |
83,885
-1,748
| -2% | -$50.8K | ﹤0.01% | 2976 |
|
|
2014
Q3 | $1.09M | Buy |
85,633
+54,313
| +173% | +$689K | ﹤0.01% | 3395 |
|
|
2014
Q2 | $628K | Buy |
+31,320
| New | +$628K | ﹤0.01% | 3537 |
|